Behind the lens and filters of Instagram is the truth about how hard it is to actually do medicine, and what Instagram doesn't exactly showcase.
In this Stanford Medicine Unplugged piece, a first-year student shares the more difficult aspects of medical school.
In the fourth post in the series A Skeptical Look at Popular Diets, physician Randall Stafford examines pros and cons of a ketogenic diet.
Nutrition experts debate the reliability of nutrition studies, their typical flaws and how researchers can perform better studies moving forward.
The prostate-specific antigen (PSA) test has become a first-resort workhorse for determining whether a male patient needs to be biopsied for prostate cancer. Simply put, …
Antibody-based hematopoietic stem cell transplants may transform the treatment of patients with blood and immune diseases including cancers.
The benefits of mindfulness — touted as a panacea for a myriad of problems from anxiety to chronic pain — has come under some debate.
If you eat a vegan or vegetarian diet, or if you're just aiming to keep your iron levels up, you probably know some of the …
Former Stanford pediatrics resident Nadine Burke Harris will be sworn in by Gov. Gavin Newsom as California’s first-ever surgeon general on Feb 11.
In the third post in A Skeptical Look at Popular Diets, clinician-researcher Randall Stafford points out the pros and cons of a vegetarian diet.
Just before the holidays, my husband whisked me off to urgent care because I received some nasty dog bites on both my hands. The incident …
In the second piece in the series A Skeptical Look at Popular Diets, clinician and researcher Randall Stafford examines the paleo diet.
What doesn't kill you makes you stronger, stand a little taller, right? Common Health blog begins a narrative post on one woman's burst-appendix survival with …
Medical residents spend more than five hours a shift in front of computer screens, much of it reviewing notes, Stanford research has found.
A team of researchers have found a new way to remove blood-producing stem cells, introducing the possibility of safer, and non-matched, transplants.
Type 1 diabetes starts out as a sneak attack by bad-actor antibodies. But scientists at Stanford and UCSF have developed an early-warning system.
